FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Kratochvil

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Brigette Vaughan; Christopher J Kratochvil
Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.
George Apostol; Michelle A Collins; David Feifel; Laura M Gault; Christopher J Kratochvil; Yili L Pritchett; Weining Z Robieson; Walid Abi-Saab; Lenard A Adler; Mario Saltarelli
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
Christopher J Kratochvil; Brigette S Vaughan; Julie A Stoner; Joan M Daughton; Brian D Lubberstedt; Desiree W Murray; Allan K Chrisman; Melissa A Faircloth; Nilda B Itchon-Ramos; Scott H Kollins; Lawrence A Maayan; Laurence L Greenhill; Lisa A Kotler; Jane Fried; John S March
A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Kratochvil (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Brigette Vaughan; Christopher J Kratochvil
Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.
Child and adolescent psychiatric clinics of North America 2012;21(4):941-55.
2012: George Apostol; Michelle A Collins; David Feifel; Laura M Gault; Christopher J Kratochvil; Yili L Pritchett; Weining Z Robieson; Walid Abi-Saab; Lenard A Adler; Mario Saltarelli
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
Psychopharmacology 2012;219(3):715-25.
2011: Christopher J Kratochvil; Brigette S Vaughan; Julie A Stoner; Joan M Daughton; Brian D Lubberstedt; Desiree W Murray; Allan K Chrisman; Melissa A Faircloth; Nilda B Itchon-Ramos; Scott H Kollins; Lawrence A Maayan; Laurence L Greenhill; Lisa A Kotler; Jane Fried; John S March
A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.
Pediatrics 2011;127(4):e862-8.
2011: Timothy E Wilens; Laura M Gault; Ann Childress; Christopher J Kratochvil; Lindsey Bensman; Coleen M Hall; Evelyn Olson; Weining Z Robieson; Tushar S Garimella; Walid M Abi-Saab; George Apostol; Mario Saltarelli
Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(1):73-84.e1.
2010: Diane E May; Christopher J Kratochvil
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Drugs 2010;70(1):15-40.
2009: Marisa Elena Domino; Barbara J Burns; Jeremy Mario; Mark A Reinecke; Benedetto Vitiello; Elizabeth B Weller; Christopher J Kratochvil; Diane E May; Norah C Feeny; Michele Robins; Mary J Hallin; Susan G Silva; John S March
Service use and costs of care for depressed adolescents: who uses and who pays?
Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53 2009;38(6):826-36.
2009: Norah C Feeny; Susan G Silva; Mark A Reinecke; Steven McNulty; Robert L Findling; Paul Rohde; John F Curry; Golda S Ginsburg; Christopher J Kratochvil; Sanjeev M Pathak; Diane E May; Betsy D Kennard; Anne D Simons; Karen C Wells; Michele Robins; David R Rosenberg; John S March
An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.
Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53 2009;38(6):814-25.
2009: Rachel H Jacobs; Susan G Silva; Mark A Reinecke; John F Curry; Golda S Ginsburg; Christopher J Kratochvil; John S March
Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents.
Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53 2009;38(6):803-13.
2009: Gregory M Rogers; Jong-Hyo Park; Marilyn J Essex; Marjorie H Klein; Susan G Silva; Rick H Hoyle; John F Curry; Norah C Feeny; Betsy Kennard; Christopher J Kratochvil; Sanjeev Pathak; Mark A Reinecke; David R Rosenberg; Elizabeth B Weller; John S March
The dysfunctional attitudes scale: psychometric properties in depressed adolescents.
Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53 2009;38(6):781-9.
2009: Christopher J Kratochvil; Diane E May; Susan G Silva; Vishal Madaan; Susan E Puumala; John F Curry; John T Walkup; Hayden O Kepley; Benedetto Vitiello; John S March
Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.
Journal of child and adolescent psychopharmacology 2009;19(5):519-27.
2009: Marisa Elena Domino; Edward Foster; Benedetto Vitiello; Christopher J Kratochvil; Barbara J Burns; Susan G Silva; Mark Reinecke; John S March
Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(7):711-20.
2009: Benedetto Vitiello; Susan G Silva; Paul Rohde; Christopher J Kratochvil; Betsy D Kennard; Mark Reinecke; Taryn L Mayes; Kelly Posner; Diane E May; John March
Suicidal events in the Treatment for Adolescents With Depression Study (TADS).
The Journal of clinical psychiatry 2009;70(5):741-7.
2009: Christopher J Kratochvil; Brigette S Vaughan; Amy Barker; Lindsey Corr; Ashley Wheeler; Vishal Madaan
Review of pediatric attention deficit/hyperactivity disorder for the general psychiatrist.
The Psychiatric clinics of North America 2009;32(1):39-56.
2009: Joan M Daughton; Christopher J Kratochvil
Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.
Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(3):240-8.
2009: Betsy D Kennard; Susan G Silva; Taryn L Mayes; Paul Rohde; Jennifer L Hughes; Benedetto Vitiello; Christopher J Kratochvil; John F Curry; Graham J Emslie; Mark Reinecke; John S March
Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
The American journal of psychiatry 2009;166(3):337-44.
2009: Betsy D Kennard; Susan G Silva; Simon Tonev; Paul Rohde; Jennifer L Hughes; Benedetto Vitiello; Christopher J Kratochvil; John F Curry; Graham J Emslie; Mark Reinecke; John March
Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes.
Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(2):186-95.
2009: Toby L Schonfeld; N Jean Amoura; Christopher J Kratochvil
iPLEDGE allegiance to the pill: evaluation of year 1 of a birth defect prevention and monitoring system.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2009;37(1):104-17.
2008: Jeffrey H Newcorn; Christopher J Kratochvil; Albert J Allen; Charles D Casat; Dustin D Ruff; Rodney J Moore; David Michelson
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
The American journal of psychiatry 2008;165(6):721-30.
2008: Brigette S Vaughan; Martin Wetzel; Christopher J Kratochvil
Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
International review of psychiatry (Abingdon, England) 2008;20(2):143-9.
2008: Laurence L Greenhill; Kelly Posner; Brigette S Vaughan; Christopher J Kratochvil
Attention deficit hyperactivity disorder in preschool children.
Child and adolescent psychiatric clinics of North America 2008;17(2):347-66, ix.
2008: Amy R Perwien; Christopher J Kratochvil; Douglas E Faries; Brigette Vaughan; Joan Busner; Keith E Saylor; Curtis M Buermeyer; Stuart Kaplan; Ralph Swindle
Emotional expression in children treated with ADHD medication: development of a new measure.
Journal of attention disorders 2008;11(5):568-79.
2008: Supriya K Bhatia; Amy J Rezac; Benedetto Vitiello; Michael A Sitorius; Bruce A Buehler; Christopher J Kratochvil
Antidepressant prescribing practices for the treatment of children and adolescents.
Journal of child and adolescent psychopharmacology 2008;18(1):70-80.
2008: Christopher J Kratochvil; Denái R Milton; Brigette S Vaughan; Laurence L Greenhill
Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy.
Child and adolescent psychiatry and mental health 2008;2(1):25.
2008: Mary Lynn Dell; Brigette S Vaughan; Christopher J Kratochvil
Ethics and the prescription pad.
Child and adolescent psychiatric clinics of North America 2008;17(1):93-111, ix.
2007: Robert L Findling; L Eugene Arnold; Laurence L Greenhill; Christopher J Kratochvil; James J McGough
Diagnosing and managing complicated ADHD.
The Journal of clinical psychiatry 2007;68(12):1963-70.
2007: Benedetto Vitiello; Christopher J Kratochvil; Susan Silva; John Curry; Mark Reinecke; Sanjeev Pathak; Bruce Waslick; Carroll W Hughes; Ernest D Prentice; Diane E May; John S March
Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(12):1642-50.
2007: Thomas J Spencer; Christopher J Kratochvil; R Bart Sangal; Keith E Saylor; Charles E Bailey; David W Dunn; Daniel A Geller; Charles D Casat; Robert S Lipetz; Rakesh Jain; Jeffrey H Newcorn; Dustin D Ruff; Peter Feldman; Amanda J Furr; Albert J Allen
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
Journal of child and adolescent psychopharmacology 2007;17(5):689-700.
2007: Melissa P DelBello; Christoph Correll; Gabrielle A Carlson; Harold E Carlson; Christopher J Kratochvil
Pharmacological management of bipolar disorder in a youth with diabetes.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(10):1375-9.
2007: Scott N Compton; Christopher J Kratochvil; John S March
Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review.
Pediatric annals 2007;36(9):586-90, 592, 594-8.
2007: Graham J Emslie; Bruce Waslick; Elizabeth B Weller; Angelica L Kloos; Ronald A Weller; Christopher J Kratochvil
Antidepressant management in the context of suicidal ideation.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(9):1222-5.
2007: Christopher J Kratochvil; David Michelson; Jeffrey H Newcorn; Margaret D Weiss; Joan Busner; Rodney J Moore; Dustin D Ruff; Janet Ramsey; Ruth Dickson; Atilla Turgay; Keith E Saylor; Stephen Luber; Brigette S Vaughan; Albert J Allen
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(9):1128-37.
2007: John S March; Peter Szatmari; Oscar G Bukstein; Allan Chrisman; Douglas Kondo; John D Hamilton; Charlotte M E Kremer; Christopher J Kratochvil
AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(9):1098-110.
2007: Diane E May; Mary J Hallin; Christopher J Kratochvil; Susan E Puumala; Lynette S Smith; Mark Reinecke; Susan G Silva; Elizabeth B Weller; Benedetto Vitiello; Alfiee Breland-Noble; John S March
Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(7):801-10.
2007: Robert L Findling; Jeffrey H Newcorn; Richard P Malone; Ayesha Waheed; Jefferson B Prince; Christopher J Kratochvil
Pharmacotherapy of aggression in a 9-year-old with ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(5):653-8.
2007: Diane E May; Christopher J Kratochvil; Susan E Puumala; Susan G Silva; Amy J Rezac; Mary J Hallin; Mark Reinecke; Benedetto Vitiello; Elizabeth B Weller; Sanjeev Pathak; Anne D Simons; John S March
A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(5):573-81.
2007: Christopher J Kratochvil; Brigette S Vaughan; Michelle L Mayfield-Jorgensen; John S March; Scott H Kollins; Desiree W Murray; Hima Ravi; Laurence L Greenhill; Lisa A Kotler; Natalya Paykina; Patricia Biggins; Julie A Stoner
A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.
Journal of child and adolescent psychopharmacology 2007;17(2):175-85.
2007: Robert L Findling; Jean A Frazier; Ginny Gerbino-Rosen; Harvey Kranzler; Sanjiv Kumra; Christopher J Kratochvil
Is there a role for clozapine in the treatment of children and adolescents?
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(3):423-8.
2007: Christopher J Kratochvil; Douglas E Faries; Brigette S Vaughan; Amy R Perwien; Joan Busner; Keith E Saylor; Stuart Kaplan; C Buermeyer; R Swindle
Emotional expression during attention-deficit/hyperactivity disorders treatment: initial assessment of treatment effects.
Journal of child and adolescent psychopharmacology 2007;17(1):51-62.
2006: Jean D Deupree; S D Smith; Christopher J Kratochvil; Daryl Bohac; Cynthia R Ellis; Jodi Polaha; David B Bylund
Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(8):877-84.
2006: Amy R Perwien; Christopher J Kratochvil; Douglas E Faries; Brigette S Vaughan; Thomas Spencer; Ronald T Brown
Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes?
Journal of child and adolescent psychopharmacology 2006;16(6):713-24.
2006: Joseph Gonzalez-Heydrich; Margaret Weiss; Mary Connolly; Kati Wambera; James E Jan; Sigita Plioplys; David W Dunn; Christopher J Kratochvil
Pharmacological management of a youth with ADHD and a seizure disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(12):1527-32.
2006: Graham J Emslie; Christopher J Kratochvil; Benedetto Vitiello; Susan Silva; Taryn L Mayes; Steven McNulty; Elizabeth Weller; Bruce Waslick; Charles D Casat; John T Walkup; Sanjeev Pathak; Paul Rohde; Kelly Posner; John March
Treatment for Adolescents with Depression Study (TADS): safety results.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(12):1440-55.
2006: John Curry; Paul Rohde; Anne Simons; Susan Silva; Benedetto Vitiello; Christopher J Kratochvil; Mark Reinecke; Norah Feeny; Karen Wells; Sanjeev Pathak; Elizabeth Weller; David R Rosenberg; Betsy D Kennard; Michele Robins; Golda S Ginsburg; John March
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(12):1427-39.
2006: Benedetto Vitiello; Paul Rohde; Susan Silva; Karen Wells; Charles D Casat; Bruce Waslick; Anne Simons; Mark Reinecke; Elizabeth Weller; Christopher J Kratochvil; John T Walkup; Sanjeev Pathak; Michele Robins; John March
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(12):1419-26.
2006: Christopher J Kratochvil; Graham J Emslie; Susan Silva; Steven McNulty; John T Walkup; John Curry; Mark Reinecke; Benedetto Vitiello; Paul Rohde; Norah Feeny; Charles D Casat; Sanjeev Pathak; Elizabeth Weller; Diane May; Taryn L Mayes; Michele Robins; John March
Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(12):1412-8.
2006: Betsy D Kennard; Susan Silva; Benedetto Vitiello; John Curry; Christopher J Kratochvil; Anne Simons; Jennifer Hughes; Norah Feeny; Elizabeth Weller; Michael Sweeney; Mark Reinecke; Sanjeev Pathak; Golda S Ginsburg; Graham J Emslie; John March
Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(12):1404-11.
2006: Jeffrey H Newcorn; David Michelson; Christopher J Kratochvil; Albert J Allen; Dustin D Ruff; Rodney J Moore
Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder.
Pediatrics 2006;118(6):e1701-6.
2006: Ronald T Brown; Amy R Perwien; Douglas E Faries; Christopher J Kratochvil; Brigette S Vaughan
Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning.
Clinical pediatrics 2006;45(9):819-27.
2006: Christopher J Kratochvil; Timothy E Wilens; Himanshu P Upadhyaya
Pharmacological management of a youth with ADHD, marijuana use, and mood symptoms.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(9):1138-41.
2006: Jayashri Sankaranarayanan; Susan E Puumala; Christopher J Kratochvil
Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003.
Current medical research and opinion 2006;22(8):1475-91.
2006: Christopher J Kratochvil; Alessandra Kazura; Deborah Deas; Catherine A Martin; Tyanne Dosh; Timothy E Wilens
Pharmacological management of a teen with significant alcohol use and depression.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(8):1011-5.
2006: Christopher J Kratochvil; Timothy E Wilens; Laurence L Greenhill; Haitao Gao; Kurt D Baker; Peter Feldman; Douglas L Gelowitz
Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(8):919-27.
2006: Timothy E Wilens; Jeffrey H Newcorn; Christopher J Kratochvil; Haitao Gao; Christine K Thomason; Ann K Rogers; Peter Feldman; Louise R Levine
Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder.
The Journal of pediatrics 2006;149(1):112-9.
2006: Christopher J Kratochvil; Christopher Varley; Thomas K Cummins; Andrés Martin
Less is more: inpatient management of a child with complex pharmacotherapy.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(5):621-4.
2006: Christopher J Kratochvil; Benedetto Vitiello; David Brent; Jeff Q Bostic; Michael W Naylor
Selecting an antidepressant for the treatment of pediatric depression.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(3):371-3.
2006: Christopher J Kratochvil; Benedetto Vitiello; John T Walkup; Graham J Emslie; Bruce Waslick; Elizabeth B Weller; William J Burke; John S March
Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?
Journal of child and adolescent psychopharmacology 2006;16(1-2):11-24.
2006: Timothy E Wilens; Christopher J Kratochvil; Jeffrey H Newcorn; Haitao Gao
Do children and adolescents with ADHD respond differently to atomoxetine?
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(2):149-57.
2006: Timothy E Wilens; Keith McBurnett; Oscar G Bukstein; James J McGough; Laurence Greenhill; Marc Lerner; Mark Stein; C Keith Conners; John Duby; Jeffrey H Newcorn; Charles E Bailey; Christopher J Kratochvil; Daniel Coury; Charles D Casat; Mary Joan C Denisco; Patricia Halstead; Leslie Bloom; Brenda A Zimmerman; Joan Gu; Kimberly M Cooper; Joseph M Lynch
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Archives of pediatrics & adolescent medicine 2006;160(1):82-90.
2006: Christopher J Kratochvil; Helen Egger; Laurence L Greenhill; James J McGough
Pharmacological management of preschool ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(1):115-8.
2005: Joseph Biederman; James M Swanson; Sharon B Wigal; Christopher J Kratochvil; Samuel W Boellner; Craig Q Earl; John Jiang; Laurence Greenhill
Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Pediatrics 2005;116(6):e777-84.
2005: Sanjeev Pathak; Christopher J Kratochvil; Gregory M Rogers; Susan Silva; Benedetto Vitiello; Elizabeth B Weller; John March
Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study.
Current psychiatry reports 2005;7(6):429-34.
2005: Christopher J Kratochvil; Melissa P DelBello; Himanshu P Upadhyaya; Janet Wozniak
Pharmacological management of new-onset bipolar disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(11):1198-200.
2005: Christopher J Kratochvil; Jeffrey H Newcorn; L Eugene Arnold; David A Duesenberg; Graham J Emslie; Humberto Quintana; Elias H Sarkis; Karen Dineen Wagner; Haitao Gao; David Michelson; Joseph Biederman
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(9):915-24.
2005: Christopher J Kratochvil; Robert L Findling; Christopher J McDougle; Lawrence Scahill; Stephanie Hamarman
Pharmacological management of agitation and aggression in an adolescent with autism.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(8):829-32.
2005: Thomas J Spencer; Jeffrey H Newcorn; Christopher J Kratochvil; Dustin D Ruff; David Michelson; Joseph Biederman
Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder.
Pediatrics 2005;116(1):e74-80.
2005: Margaret Danielle Weiss; Rosemary Tannock; Christopher J Kratochvil; David Dunn; Jesus Velez-Borras; Christine Thomason; Roy Tamura; Douglas Kelsey; Linda Stevens; Albert J Allen
A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(7):647-55.
2005: Christopher J Kratochvil; Marybeth Lake; Steven R Pliszka; John T Walkup
Pharmacological management of treatment-induced insomnia in ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(5):499-501.
2005: Christopher J Kratochvil; Karen Dineen Wagner; Graham J Emslie; John March
Pharmacological management of treatment-resistant pediatric depression.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(2):198-200.
2005: Jodi Polaha; Stephanie L Cooper; Tawnya Meadows; Christopher J Kratochvil
The assessment of attention-deficit/hyperactivity disorder in rural primary care: the portability of the American Academy of Pediatrics guidelines to the "real world".
Pediatrics 2005;115(2):e120-6.
2004: Amy R Perwien; Douglas E Faries; Christopher J Kratochvil; Calvin R Sumner; Douglas Kelsey; Albert J Allen
Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine.
Journal of developmental and behavioral pediatrics : JDBP 2004;25(4):264-71.
2004: John March; Christopher J Kratochvil; Gregory N. Clarke; William Beardslee; Albert Derivan; Graham J Emslie; Evelyn P Green; John H Heiligenstein; Stephen P Hinshaw; Kimberly Hoagwood; Peter Jensen; Philip W Lavori; Henrietta Leonard; James McNulty; M Alex Michaels; Andrew Mossholder; Trina Osher; Theodore Petti; Ernest Prentice; Benedetto Vitiello; Karen Wells
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(8):1046-56.
2004: Stephen P Hinshaw; Kimberly Hoagwood; Peter S Jensen; Christopher J Kratochvil; Leonard Bickman; Gregory N. Clarke; Howard B Abikoff; Marc S Atkins; Benedetto Vitiello
AACAP 2001 research forum: challenges and recommendations regarding recruitment and retention of participants in research investigations.
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(8):1037-45.
2004: Christopher J Kratochvil; Brigette S Vaughan; Joan M Daughton; Michelle L Mayfield-Jorgensen; William J Burke
Atomoxetine in the treatment of attention deficit hyperactivity disorder.
Expert review of neurotherapeutics 2004;4(4):601-11.
2004: Louis S Matza; Anne M Rentz; Kristina Secnik; Andrine R Swensen; Dennis A Revicki; David Michelson; Thomas Spencer; Jeffrey H Newcorn; Christopher J Kratochvil
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder.
Journal of developmental and behavioral pediatrics : JDBP 2004;25(3):166-74.
2004: Christopher J Kratochvil; Laurence L Greenhill; John S March; William J Burke; Brigette S Vaughan
The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder.
CNS drugs 2004;18(14):957-66.
2003: Christopher J Kratochvil; Brigette S Vaughan; Martin J Harrington; William J Burke
Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder.
Expert opinion on pharmacotherapy 2003;4(7):1165-74.
2003: Laurence L Greenhill; Peter S Jensen; Howard B Abikoff; Jeffery L Blumer; Joseph DeVeaugh-Geiss; Celia Fisher; Kimberly Hoagwood; Christopher J Kratochvil; Benjamin B Lahey; Thomas Laughren; James F Leckman; Theodore A Petti; Kayla Pope; David Shaffer; Benedetto Vitiello; Charles Zeanah
Developing strategies for psychopharmacological studies in preschool children.
Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(4):406-14.
2002: Thomas Spencer; John H Heiligenstein; Joseph Biederman; Douglas E Faries; Christopher J Kratochvil; C Keith Conners; William Z Potter
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2002;63(12):1140-7.
2002: Joseph Biederman; John H Heiligenstein; Douglas E Faries; Nora Galil; Ralf Dittmann; Graham J Emslie; Christopher J Kratochvil; Harry F Laws; Kory J Schuh
Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.
Pediatrics 2002;110(6):e75.
2002: David Michelson; Albert J Allen; Joan Busner; Charles D Casat; David Dunn; Christopher J Kratochvil; Jeffrey H Newcorn; Floyd R Sallee; R Bart Sangal; Keith E Saylor; Scott West; Douglas Kelsey; Joachim F Wernicke; Nancy J Trapp; Donald Harder
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
The American journal of psychiatry 2002;159(11):1896-901.
2002: Christopher J Kratochvil; Martin J Harrington; William J Burke; John S March
Pharmacotherapy of childhood anxiety disorders.
Current psychiatry reports 2002;4(4):264-9.
2002: Christopher J Kratochvil; John H Heiligenstein; Ralf Dittmann; Thomas J Spencer; Joseph Biederman; Joachim F Wernicke; Jeffrey H Newcorn; Charles D Casat; Denái Milton; David Michelson
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(7):776-84.
2001: Christopher J Kratochvil; Daryl Bohac; M Harrington; N Baker; D May; William J Burke
An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder.
Journal of child and adolescent psychopharmacology 2001;11(2):167-70.